DOCSLIB.ORG

Dr.Hussam Pharmacognocy Lec: 2 Pyridine Piperidine Alkaloids

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dr.Hussam Pharmacognocy Lec: 2 Pyridine Piperidine Alkaloids Lec: 2 pharmacognocy Dr.hussam Pyridine_ piperidine alkaloids: The alkaloids in this group contain Pyridine or Piperidine in the molecule. The important alkaloids in this group are Nicotine, Coniine, Arecoline, Lobeline etc. Drugs containing pyridine_piperidine Alkaloids: 1-Lobelia or (Indian tobacco): is the dried leaves & tops of Lobelia inflata F: Lobeliaceae. The drug contains 14 alkaloids, of which lobeline is the major & most important. Lobeline: (-)-lobeline or alpha lobeline: Similar but weaker pharmacological effects to those of nicotine on the peripheral circulation, neuromuscular junctions, and CNS. For this reason, Lobeline sulphate was formerly incorporated in chewing tablets or lozenges that were intended to aid in breaking the tobacco habit (smoking deterrents). Lobeline had placebo effect on decreasing the physical craving for cigarettes.Traditionally used by the Native Americans for asthma& Chronic bronchitis(respiratory stimulant) .Injection of lobeline hydrochloride is used in the resuscitation of newborn infants. 2-Areca, Areca nut or Betel Nut: Is the dried, ripe seed of Areca catechu (F. Palmaceae). It is rich in group of alkaloids mainly nicotinic acid derivatives: 1-arecoline 2-arecaidine 1 Lec: 2 pharmacognocy Dr.hussam 3-guvacine 4-guvacaline (guvacin methyl ester) It is derived from aspartic acid & glycerol. It was used as anthelmintic in veterinary practice and is employed as taenifuge & vermicide. 3-Tobacco: is the dried leaf of Nicotiana tabacum F: Solanaceae. It is cultivated for smoking, it contains alkaloids from 0.6-0.9%.the importance of them is nicotine which is an oily liquid alkaloid, it is colorless liquid but when oxidized convert to yellow color. Nicotine: in small doses can act as respiratory stimulant, but in large dose it causes respiratory depression. It is a ganglionic (nicotinic) cholinergic receptor agonist. The free base is more toxic than its salt; nicotine is toxic to human due to its effect on nervous system. Recent studies suggest that nicotine can improve memory (reduces risk of Alzheimer) by stimulating the transmission of nerve impulses. Generally, it is used as antiseptic. Nicotine is a toxic alkaloid & a dose of 40mg is said to be fatal to humans. Death results from respiratory paralysis. The average cigarette may contain 10-14mg of nicotine & a cigar about 70mg & much attention has focused on the relationship among lung cancer, smoking & nicotine. However nicotine has pronounced effects on the cardiovascular system, where peripheral vasoconstriction, atrial tachycardia & an increase in both systolic & diastolic blood pressure are observed. It is worth noting that 50% of all smokers die of heart disease & 20% of lung cancer. The carcinogenicity of tobacco is probably not due to nicotine but rather to a far more potent carcinogen (N-nitroso nornicotine). It is found in cigarettes, cigar& chewing tobacco at levels in the range of 2-90 ppm. The carcinogenicity of N-nitroso nornicotine derivatives is well known & considered hazardous to health. Note: chronic use of nicotine may result in psychological and physical dependence. As a temporary aid for the cessation of cigarette smoking, the drug is available in transdermal patch and it is also available bound to an ion exchange resin in a chewing gum base. These alternative sources 2 Lec: 2 pharmacognocy Dr.hussam of nicotine help reduce the withdrawal symptoms associated with nicotine addiction. Nicotine N-nitroso nor nicotine Biosynthesis of nicotine: Nicotine is biosynthesized from ornithine +aspartic acid+ glyceraldehyde. 4-Pomegranate: it is the fruit or fruit rind or bark of stem of Punica granatum F: Punicaceae It contains many alkaloids namely: Pelletierine Pseudo Pelletierine It is used as anthelmintic. It is biosynthesized from lysine & acetate group. 5- Conium or poison Hemlock: It is the full grown but unripe fruit of Conium maculatum F: Umbellifareae. It contains number of alkaloids, the important of which are Coniine& Conhydrine 3 Lec: 2 pharmacognocy Dr.hussam Coniine Conhydrine It is used as antispasmodic and sedative; it is synthesized from lysine and two acetyl molecules. Coniine is very poisonous, lethal dose 120-300 mg, death may occur after ½ hr (or may prolonged to 3 –12 hrs). 2-Tropane alkaloids: Tropane is a dicyclic compound formed by the condensation of a pyrrolidine precursor (ornithine) with 3 carbon atoms derived from acetate. Both pyrrolidine and piperidine ring system can be recognized in the molecule. The 3-hydroxy derivative of tropane is known as tropine.it is esterification with (-) – tropic acid yields hyoscyamine (tropine- tropate) which may racemized to form atropine. Biosynthesis of tropane alkaloids: because of the commercial importance of hyoscyamine & scopolamine, investigation of their biosynthesis has been extensive, especially in Datura species. Feeding studies with labeled ornithine have revealed that this amino acid is incorporated to form the pyrrolidine ring of tropine. The remaining 3 carbon atoms are derived from acetate & thus complete the piperidine 4 Lec: 2 pharmacognocy Dr.hussam moity. Methylation results via transmethylation from methionine to complete the tropine nucleus. On the other hand from phenylalanine, tropic acid is formed via rearrangement and other reactions. Esterification of tropine and tropic acid results in the formation of Hyoscyamine and thus other Tropane alkaloids are synthesized. The (-) isomer is hyoscyamine , the (+) isomer is not found in the plant ,(±) isomer is the atropine. Hyoscyamine is more active than atropine. Hyoscine is an epoxide of atropine & it is the (-) isomer. The (±) isomer of scopolamine is atrosine. When (-) hyoscyamine is extracted from the plants in which it occurs, it is usually racemized during the process & thus converted to the (±) compound which is atropine. Semisynthetic 5 Lec: 2 pharmacognocy Dr.hussam derivatives ex. Hyoscine N-butylbromide (buscopane) is of medicinal importance. Drugs containing alkaloids: 1-Belladonna leaf (deadly nightshade leaf): two parts are official, the root & the leaf. It is the dried leaf or root of Atropa belladonna F: Solanaceae.The root is richer than the leaf in alkaloids. Most of the alkaloids found is hyoscyamine , hyoscine(scopolamine) & traces amount of atropine base. Uses and Doses: Belladonna acts as antimuscarnic agent which accounts for it's use as spasmolytic drug, it used as adjunctive therapy in the treatment of peptic ulcer, functional digestive disorders including ulcerative colitis, diarrhea & pancreatitis also it has anticholinergic properties so it used to control of spasm of the urinary tract. Also it dilates the pupil; it is therefore a parasympatholytic & mydriatic. Belladonna leaf is commonly administered in form of the belladonna tincture; the usual dose of the tincture is 0.6ml t.i.d. (30mg alkaloids/100ml). 2-Hyoscyamus or henbane: dried leaves & flowering tops of Hyoscyamus niger F: Solanaceae.it contains 0.04% of total alkaloid calculated as hyoscyamine. Also contains hyoscine & traces of atropine. 3-stramonium: Solanaceous alkaloids: The principle alkaloids of this group are hyoscyamine, atropine and scopolamine(hyoscine) 1- Atropine: used as a mydriatic, also used as antidote in cases of poisoning caused by organophosphate insecticides, it has antisecretory effect used to reduce respiratory secretion & gastric secretion. 2- Scopolamine : it has a depressant activity on the central nervous system and is used to treat motion sickness(prevent nausea and vomiting) 6 Lec: 2 pharmacognocy Dr.hussam 3- Hyoscyamine: is anticholinergic, it is used to aid in the control of gastric secretion, visceral spasm also it reduces rigidity and tremor in Parkinsonism. Note: at usual therapeutic doses, scopolamine is a central nervous depressant whereas atropine is a stimulant. For this reason, scopolamine hydrobromide is used for preanesthetic sedation in conjunction with analgesics. 4-Cocaine: it is a habit forming drug from the leaves of Erythroxylum coca F: Erythroxylaceae. The plant is also called coca or coca leaves. coca contain 3 types of alkaloids: 1-dervaitives of ecgonine (Cocaine, cinnamylcocaine, α&β- truxilline) ecgonine 2-Pseudotropine (tropacocaine,valerine) 3-Hygrine(hygroline , cuscohygrine) Only the ecgonine derivatives are commercially important. The most important of these alkaloids is cocaine. Cocaine is the methyl ester of benzoylecgonine. When hydrolyzed, it splits into ecgonine, benzoic acid & methyl alcohol. Cocaine & cocaine HCl as agents of abuse are generally inhaled or sniffed& are rapidly absorbed across the pharyngeal mucosa resulting in cerebral stimulation & euphoria. Cocaine HCl is a local anesthetic. It is applied topically to mucous membrane as 2-5% solution. Cocaine HCl is an ingredient in Brompton's cocktail, which is widely used to control sever pain associated with terminal cancer. Because of it is CNS stimulant properties, cocaine counteracts the narcotic induced sedation & 7 Lec: 2 pharmacognocy Dr.hussam respiratory depression associated with the narcotic analgesic ingredient (morphine or heroin) used in the cocktail.it also potentiate the analgesic effect. In continuous use, they are narcotics. Coca leaves have long been chewed by the South American, Indians to prevent hunger & to increase endurance. 5-Withania: is the dried root of Withania somnfera F: Solanaceae. Recent studies have shown that withania which is closely related botanically to Belladonna & Hyoscyamus contains about a dozen of alkaloids e.g. tropine, pseudotropine, hygrine, cuscohygrine, anaferine (two piperidine moieties) The end Dr. Hussam H. Sahib 8 .
Load more

Recommended publications
  • Arecoline Promotes Migration of A549 Lung Cancer Cells Through Activating the EGFR/Src/FAK Pathway
    toxins Article Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway Chih-Hsiang Chang 1,†, Mei-Chih Chen 2,3,†, Te-Huan Chiu 1 , Yu-Hsuan Li 1, Wan-Chen Yu 1, Wan-Ling Liao 1, Muhammet Oner 1, Chang-Tze Ricky Yu 4, Chun-Chi Wu 5, Tsung-Ying Yang 6, Chieh-Lin Jerry Teng 7, Kun-Yuan Chiu 8, Kun-Chien Chen 6, Hsin-Yi Wang 9, Chia-Herng Yue 10, Chih-Ho Lai 11 , Jer-Tsong Hsieh 12 and Ho Lin 1,13,14,* 1 Department of Life Sciences, National Chung Hsing University, Taichung 40227, Taiwan; [email protected] (C.-H.C.); [email protected] (T.-H.C.); [email protected] (Y.-H.L.); [email protected] (W.-C.Y.); [email protected] (W.-L.L.); [email protected] (M.O.) 2 Medical Center for Exosomes and Mitochondria Related Diseases, China Medical University Hospital, Taichung 40447, Taiwan; [email protected] 3 Department of Nursing, Asia University, Taichung 41345, Taiwan 4 Department of Applied Chemistry, National Chi Nan University, Nantou 54561, Taiwan; [email protected] 5 Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan; [email protected] 6 Division of Chest Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan; [email protected] (T.-Y.Y.); [email protected] (K.-C.C.) 7 Division of Hematology/Medical Oncology, Taichung Veterans General Hospital, Taichung 40705, Taiwan; [email protected] 8 Division of Urology, Taichung Veterans General Hospital, Taichung 40705, Taiwan; [email protected] 9 Department of Nuclear Medicine, Taichung
    [Show full text]
  • Upregulation of Peroxisome Proliferator-Activated Receptor-Α And
    Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer Chih-Yang Wang, Ying-Jui Chao, Yi-Ling Chen, Tzu-Wen Wang, Nam Nhut Phan, Hui-Ping Hsu, Yan-Shen Shan, Ming-Derg Lai 1 Supplementary Table 1. Demographics and clinical outcomes of five patients with ampullary cancer Time of Tumor Time to Age Differentia survival/ Sex Staging size Morphology Recurrence recurrence Condition (years) tion expired (cm) (months) (months) T2N0, 51 F 211 Polypoid Unknown No -- Survived 193 stage Ib T2N0, 2.41.5 58 F Mixed Good Yes 14 Expired 17 stage Ib 0.6 T3N0, 4.53.5 68 M Polypoid Good No -- Survived 162 stage IIA 1.2 T3N0, 66 M 110.8 Ulcerative Good Yes 64 Expired 227 stage IIA T3N0, 60 M 21.81 Mixed Moderate Yes 5.6 Expired 16.7 stage IIA 2 Supplementary Table 2. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of an ampullary cancer microarray using the Database for Annotation, Visualization and Integrated Discovery (DAVID). This table contains only pathways with p values that ranged 0.0001~0.05. KEGG Pathway p value Genes Pentose and 1.50E-04 UGT1A6, CRYL1, UGT1A8, AKR1B1, UGT2B11, UGT2A3, glucuronate UGT2B10, UGT2B7, XYLB interconversions Drug metabolism 1.63E-04 CYP3A4, XDH, UGT1A6, CYP3A5, CES2, CYP3A7, UGT1A8, NAT2, UGT2B11, DPYD, UGT2A3, UGT2B10, UGT2B7 Maturity-onset 2.43E-04 HNF1A, HNF4A, SLC2A2, PKLR, NEUROD1, HNF4G, diabetes of the PDX1, NR5A2, NKX2-2 young Starch and sucrose 6.03E-04 GBA3, UGT1A6, G6PC, UGT1A8, ENPP3, MGAM, SI, metabolism
    [Show full text]
  • NIH Public Access Author Manuscript Neuroscience
    NIH Public Access Author Manuscript Neuroscience. Author manuscript; available in PMC 2016 January 22. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Neuroscience. 2015 January 22; 0: 775–797. doi:10.1016/j.neuroscience.2014.10.044. Early-life Exposure to the SSRI Paroxetine Exacerbates Depression-like Behavior in Anxiety/Depression-prone rats Matthew E. Glover1, Phyllis C. Pugh1, Nateka L. Jackson1, Joshua L. Cohen1, Andrew D. Fant2, Huda Akil3, and Sarah M. Clinton1,§ 1Department of Psychiatry and Behavioral Neurobiology, University of Alabama-Birmingham, USA 2Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA 3Molecular and Behavioral Neuroscience Institute, University of Michigan, USA Abstract Selective serotonin reuptake inhibitor (SSRI) antidepressants are the mainstay treatment for the 10–20% of pregnant and postpartum women who suffer major depression, but the effects of SSRIs on their children’s developing brain and later emotional health are poorly understood. SSRI use during pregnancy can elicit antidepressant withdrawal in newborns and increase toddlers’ anxiety and social avoidance. In rodents, perinatal SSRI exposure increases adult depression- and anxiety- like behavior, although certain individuals are more vulnerable to these effects than others. Our study establishes a rodent model of individual differences in susceptibility to perinatal SSRI exposure, utilizing selectively-bred Low Responder (bLR) and High Responder (bHR) rats that were previously bred for high versus low behavioral response to novelty. Pregnant bHR/bLR females were chronically treated with the SSRI paroxetine (10 mg/kg/day p.o.) to examine its effects on offspring’s emotional behavior and gene expression in the developing brain.
    [Show full text]
  • EUROPEAN COMMISSION Brussels, 11.7.2011 SEC(2011)
    EUROPEAN COMMISSION Brussels, 11.7.2011 SEC(2011) 912 final COMMISSION STAFF WORKING PAPER on the assessment of the functioning of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances Accompanying the document REPORT FROM THE COMMISSION on the assessment of the functioning of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances {COM(2011) 430 final} EN EN TABLE OF CONTENTS 1. Introduction...................................................................................................................3 2. Methodology.................................................................................................................4 3. Key findings from the 2002 evaluation of the Joint Action on synthetic drugs ...........5 4. Overview of notifications, types of substances and trends at EU level 2005-2010......7 5. Other EU legislation relevant for the regulation of new psychoactive substances.....12 6. Functioning of the Council Decision on new psychoactive substances .....................16 7. Findings of the survey among Member States............................................................17 7.1. Assessment of the Council Decision ..........................................................................17 7.2. Stages in the functioning of the Council Decision .....................................................18 7.3. National responses to new psychoactive substances ..................................................20
    [Show full text]
  • Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr
    Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Crizotinib (PF-02341066) 1 4 55 Docetaxel 1 5 98 Anastrozole 1 6 25 Cladribine 1 7 23 Methotrexate 1 8 -187 Letrozole 1 9 65 Entecavir Hydrate 1 10 48 Roxadustat (FG-4592) 1 11 19 Imatinib Mesylate (STI571) 1 12 0 Sunitinib Malate 1 13 34 Vismodegib (GDC-0449) 1 14 64 Paclitaxel 1 15 89 Aprepitant 1 16 94 Decitabine 1 17 -79 Bendamustine HCl 1 18 19 Temozolomide 1 19 -111 Nepafenac 1 20 24 Nintedanib (BIBF 1120) 1 21 -43 Lapatinib (GW-572016) Ditosylate 1 22 88 Temsirolimus (CCI-779, NSC 683864) 1 23 96 Belinostat (PXD101) 1 24 46 Capecitabine 1 25 19 Bicalutamide 1 26 83 Dutasteride 1 27 68 Epirubicin HCl 1 28 -59 Tamoxifen 1 29 30 Rufinamide 1 30 96 Afatinib (BIBW2992) 1 31 -54 Lenalidomide (CC-5013) 1 32 19 Vorinostat (SAHA, MK0683) 1 33 38 Rucaparib (AG-014699,PF-01367338) phosphate1 34 14 Lenvatinib (E7080) 1 35 80 Fulvestrant 1 36 76 Melatonin 1 37 15 Etoposide 1 38 -69 Vincristine sulfate 1 39 61 Posaconazole 1 40 97 Bortezomib (PS-341) 1 41 71 Panobinostat (LBH589) 1 42 41 Entinostat (MS-275) 1 43 26 Cabozantinib (XL184, BMS-907351) 1 44 79 Valproic acid sodium salt (Sodium valproate) 1 45 7 Raltitrexed 1 46 39 Bisoprolol fumarate 1 47 -23 Raloxifene HCl 1 48 97 Agomelatine 1 49 35 Prasugrel 1 50 -24 Bosutinib (SKI-606) 1 51 85 Nilotinib (AMN-107) 1 52 99 Enzastaurin (LY317615) 1 53 -12 Everolimus (RAD001) 1 54 94 Regorafenib (BAY 73-4506) 1 55 24 Thalidomide 1 56 40 Tivozanib (AV-951) 1 57 86 Fludarabine
    [Show full text]
  • Vaginal Administration of Contraceptives
    Scientia Pharmaceutica Review Vaginal Administration of Contraceptives Esmat Jalalvandi 1,*, Hafez Jafari 2 , Christiani A. Amorim 3 , Denise Freitas Siqueira Petri 4 , Lei Nie 5,* and Amin Shavandi 2,* 1 School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK 2 BioMatter Unit, École Polytechnique de Bruxelles, Université Libre de Bruxelles, Avenue F.D. Roosevelt, 50-CP 165/61, 1050 Brussels, Belgium; [email protected] 3 Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, 1200 Brussels, Belgium; [email protected] 4 Fundamental Chemistry Department, Institute of Chemistry, University of São Paulo, Av. Prof. Lineu Prestes 748, São Paulo 05508-000, Brazil; [email protected] 5 College of Life Sciences, Xinyang Normal University, Xinyang 464000, China * Correspondence: [email protected] (E.J.); [email protected] (L.N.); [email protected] (A.S.); Tel.: +32-2-650-3681 (A.S.) Abstract: While contraceptive drugs have enabled many people to decide when they want to have a baby, more than 100 million unintended pregnancies each year in the world may indicate the contraceptive requirement of many people has not been well addressed yet. The vagina is a well- established and practical route for the delivery of various pharmacological molecules, including contraceptives. This review aims to present an overview of different contraceptive methods focusing on the vaginal route of delivery for contraceptives, including current developments, discussing the potentials and limitations of the modern methods, designs, and how well each method performs for delivering the contraceptives and preventing pregnancy.
    [Show full text]
  • Phencyclidine: an Update
    Phencyclidine: An Update U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse and Mental Health Administration Phencyclidine: An Update Editor: Doris H. Clouet, Ph.D. Division of Preclinical Research National Institute on Drug Abuse and New York State Division of Substance Abuse Services NIDA Research Monograph 64 1986 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administratlon National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20657 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 NIDA Research Monographs are prepared by the research divisions of the National lnstitute on Drug Abuse and published by its Office of Science The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. SIDNEY COHEN, M.D. Temple University School of Medicine Los Angeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic lnstitute National Federation of Parents for Troy, New York Drug Free Youth RICHARD E. BELLEVILLE, Ph.D. Omaha, Nebraska NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTEMAN Langley Porter Neuropsychiatric lnstitute Alcohol and Drug Problems Association San Francisco, California of North America Washington, D.C. DENISE KANDEL, Ph.D GILBERT J. BOTV N, Ph.D. College of Physicians and Surgeons of Cornell University Medical College Columbia University New York, New York New York, New York JOSEPH V.
    [Show full text]
  • Tropane and Granatane Alkaloid Biosynthesis: a Systematic Analysis
    Office of Biotechnology Publications Office of Biotechnology 11-11-2016 Tropane and Granatane Alkaloid Biosynthesis: A Systematic Analysis Neill Kim Texas Tech University Olga Estrada Texas Tech University Benjamin Chavez Texas Tech University Charles Stewart Jr. Iowa State University, [email protected] John C. D’Auria Texas Tech University Follow this and additional works at: https://lib.dr.iastate.edu/biotech_pubs Part of the Biochemical and Biomolecular Engineering Commons, and the Biotechnology Commons Recommended Citation Kim, Neill; Estrada, Olga; Chavez, Benjamin; Stewart, Charles Jr.; and D’Auria, John C., "Tropane and Granatane Alkaloid Biosynthesis: A Systematic Analysis" (2016). Office of Biotechnology Publications. 11. https://lib.dr.iastate.edu/biotech_pubs/11 This Article is brought to you for free and open access by the Office of Biotechnology at Iowa State University Digital Repository. It has been accepted for inclusion in Office of Biotechnology Publicationsy b an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Tropane and Granatane Alkaloid Biosynthesis: A Systematic Analysis Abstract The tropane and granatane alkaloids belong to the larger pyrroline and piperidine classes of plant alkaloids, respectively. Their core structures share common moieties and their scattered distribution among angiosperms suggest that their biosynthesis may share common ancestry in some orders, while they may be independently derived in others. Tropane and granatane alkaloid diversity arises from the myriad modifications occurring ot their core ring structures. Throughout much of human history, humans have cultivated tropane- and granatane-producing plants for their medicinal properties. This manuscript will discuss the diversity of their biological and ecological roles as well as what is known about the structural genes and enzymes responsible for their biosynthesis.
    [Show full text]
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
    WHO/PSM/QSM/2006.3 The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances 2006 Programme on International Nonproprietary Names (INN) Quality Assurance and Safety: Medicines Medicines Policy and Standards The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 © World Health Organization 2006 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
    [Show full text]
  • On the Approximation of the Laws of the Member States Relating to Cosmetic Products (76/768/EEC )
    27 . 9 . 76 Official Journal of the European Communities No L 262/169 COUNCIL DIRECTIVE of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products (76/768/EEC ) THE COUNCIL OF THE EUROPEAN COMMUNITIES, regards the composition, labelling and packaging of cosmetic products ; Having regard to the Treaty establishing the Euro­ pean Economic Community, and in particular Whereas this Directive relates only to cosmetic prod­ Article 100 thereof, ucts and not to pharmaceutical specialities and medicinal products ; whereas for this purpose it is necessary to define the scope of the Directive by Having regard to the proposal from the Commission, delimiting the field of cosmetics from that of phar­ maceuticals ; whereas this delimitation follows in particular from the detailed definition of cosmetic Having regard to the opinion of the European Parlia­ products, which refers both to their areas of appli­ ment ( 1 ), cation and to the purposes of their use; whereas this Directive is not applicable to the products that fall Having regard to the opinion of the Economic and under the definition of cosmetic product but are Social Committee (2 ), exclusively intended to protect from disease; whereas, moreover, it is advisable to specify that certain prod­ ucts come under this definition, whilst products Whereas the provisions laid down by law, regulation containing substances or preparations intended to be or administrative action in force in the Member ingested, inhaled, injected or implanted in the human States
    [Show full text]
  • Introduction to Alkaloids
    MASARYKOVA UNIVERZITA Pedagogická fakulta Katedra fyziky, chemie a odborného vzdělávání Introduction to Alkaloids Bakalářská práce Brno 2017 Vedoucí práce: Autor práce: Mgr. Jiří Šibor, Ph.D. Aleš Bárta Prohlášení: „Prohlašuji, že jsem bakalářskou práci vypracoval samostatně, s využitím pouze citovaných pramenů, dalších informací a zdrojů v souladu s Disciplinárním řádem pro studenty Pedagogické fakulty Masarykovy univerzity a se zákonem č. 121/2000 Sb., o právu autorském, o právech souvisejících s právem autorským a o změně některých zákonů (autorský zákon), ve znění pozdějších předpisů.“ V Brně dne: 28.3.2017 ………………….. Aleš Bárta 2 Acknowledgement: I would like to thank to Mgr. Jiří Šibor, Ph.D. not only for the help he provided me with but also for his endless patience during our sessions which helped me complete this bachelor thesis. 3 Obsah INTRODUCTION AND GOALS .............................................................................................. 6 WORKING APPROACH .......................................................................................................... 7 1 ALKALOIDS – CHARACTERISTICS ................................................................................. 8 1.1 HISTORY OF ALKALOID CHEMISTRY ................................................................................ 11 1.2 SIGNIFICANCE OF ALKALOID FORMATION FOR THE PRODUCER ORGANISM .................... 11 1.3 APPLICATIONS ................................................................................................................... 11
    [Show full text]
  • Tropine Dehydrogenase: Purification, Some Properties and an Evaluation of Its Role in the Bacterial Metabolism of Tropine Barbara A
    Biochem. J. (1995) 307, 603-608 (Printed in Great Britain) 603 Tropine dehydrogenase: purification, some properties and an evaluation of its role in the bacterial metabolism of tropine Barbara A. BARTHOLOMEW, Michael J. SMITH, Marianne T. LONG, Paul J. DARCY, Peter W. TRUDGILL and David J. HOPPER* Institute of Biological Sciences, University of Wales, Aberystwyth, Dyfed SY23 3DD, Wales, U.K. Tropine dehydrogenase was induced by growth of Pseudomonas number of related compounds. The apparent Kms were 6.06 ,uM AT3 on atropine, tropine or tropinone. It was NADP+-dependent for tropine and 73.4,M for nortropine with the specificity and gave no activity with NADI. The enzyme was very unstable constant (Vmax/Km) for tropine 7.8 times that for pseudotropine. but a rapid purification procedure using affinity chromatography The apparent Km for NADP+ was 48 ,uM. The deuterium of [3- that gave highly purified enzyme was developed. The enzyme 2H]tropine and [3-2H]pseudotropine was retained when these gave a single band on isoelectric focusing with an isoelectric compounds were converted into 6-hydroxycyclohepta- 1 ,4-dione, point at approximately pH 4. The native enzyme had an Mr of an intermediate in tropine catabolism, showing that the tropine 58000 by gel filtration and 28000 by SDS/PAGE and therefore dehydrogenase, although induced by growth on tropine, is not consists of two subunits of equal size. The enzyme displayed a involved in the catabolic pathway for this compound. 6-Hydroxy- narrow range of specificity and was active with tropine and cyclohepta-1,4-dione was also implicated as an intermediate in nortropine but not with pseudotropine, pseudonortropine, or a the pathways for pseudotropine and tropinone catabolism.
    [Show full text]